Pegylated interferon alpha-2B (PEG-Intron) for metastatic renal cell cancer (mRCC): Results of a phase II clinical trial and biologic correlates of response Meeting Abstract


Authors: Kondagunta, G. V.; Bacik, J.; Ishill, N.; Reuter, V.; Schwartz, L. H.; Korkola, J.; Deluca, J.; Sweeney, S.; Chaganti, R. S. K.; Motzer, R. J.
Abstract Title: Pegylated interferon alpha-2B (PEG-Intron) for metastatic renal cell cancer (mRCC): Results of a phase II clinical trial and biologic correlates of response
Meeting Title: 42nd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 24
Issue: 18 Suppl. Pt. 1
Meeting Dates: 2006 Jun 2-6
Meeting Location: Atlanta, GA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2006-06-01
Start Page: 223S
Language: English
ACCESSION: WOS:000239009401325
PROVIDER: wos
Notes: --- - Meeting Abstract: 4528 - 42nd Annual Meeting of the American-Society-of-Clinical-Oncology - JUN 02-06, 2006 - Atlanta, GA - S - Part 1 - "Source: Wos"
MSK Authors
  1. Robert Motzer
    744 Motzer
  2. Lawrence H Schwartz
    281 Schwartz
  3. James E Korkola
    24 Korkola
  4. Victor Reuter
    899 Reuter
  5. Raju S K Chaganti
    260 Chaganti
  6. Nicole Marie Leoce
    86 Leoce
  7. John Vito K Deluca
    8 Deluca
  8. Jennifer M Bacik
    46 Bacik